两种新型丁二炔衍生物的合成

以3,5-二溴-1-｛3-（十二烷氧基）-2-［（十二烷氧基）甲基］丙氧基｝苯和2-甲基-3-丁炔-2-醇为原料,经选择性Sonogashira偶联反应,Sonogashira偶联反应和去硅保护基反应制得中间体--3-乙炔基-5-（3-甲基-3-羟基)-丁炔基-1-（3-十二烷氧基）-2-｛［（十二烷氧基）甲基］丙氧基｝苯（6）; 6经改良的Glaser偶联反应(CuI为催化剂,Et₃N为溶剂)合成了一个新型的丁二炔衍生物（1）。 6与2,2′-［（2,5-二碘-1,4-亚苯基）双（氧基）］双（四氢-2H-吡喃）经Sonogashira偶联,脱 THP保护基和改良的Glaser偶联反应合成了一个新型的丁二炔衍生物（2）。中间体,1和2的结构经¹H NMR, ¹³C NMR和MALDI-TOF-MS表征。     

吡啶高三蝶烯的合成

2-溴-4-甲基吡啶（1）经氯代和碘代反应合成了2-溴-4-碘甲基吡啶（3）,3和蒽酮（4）反应生成10,10-二（2-溴-4-吡啶甲基）-9（10H）蒽酮（5）,5在3 MPa下与NaOCH3反应得到10,10-二（2-甲氧基-4-吡啶甲基）-9（10H）蒽酮（6）,6经硼氢化钠还原得到蒽醇（7）,7在对甲苯磺酸催化...     

新型CCR5拮抗剂——N-【1-{5-溴-2-[(4-氯苄基)氧基]苄基}-4-哌啶基】-N-乙基吡啶甲酰胺的合成

以5-溴水杨醛和4-氯苄氯为原料,通过消去、还原及溴化反应制得中间体4-溴-2-溴甲基-1-[(4-溴苄基)氧]苯(3);哌啶-4-酮经Boc保护、还原等4步反应制得中间体N-乙基-N-(4-哌啶基)吡啶甲酰胺(7);3与7通过消去反应合成了一种新型CCR5拮抗剂——N-【1-{5-溴-2-[(4-氯苄基)氧基]苄基}-4-哌啶基】-N-乙基吡啶甲酰胺,其结构经1H NMR,13C NMR和ESI-MS表征。     

2-氟-6-三氟甲基苄胺的合成新方法

以2-甲基-3-三氟甲基苯胺（1）为原料,经Balz-Schiemann反应制得3-氟-2-甲基三氟甲苯（3）;3经溴代制得2-氟-6-三氟甲基苄溴(4）,最后经Gabriel反应合成2-氟-6-三氟甲基苄胺,总收率53.4%,其结构经¹H NMR和MS(ESI)确证。     

2-氯甲基-3-甲基-4-[(3-甲氧基)丙氧基]-吡啶盐酸盐的合成

以2,3-二甲基吡啶为原料,经6步反应合成了雷贝拉唑的关键中间体--2-氯甲基-3-甲基-4-[(3-甲氧基)丙氧基]-吡啶盐酸盐,总收率14.1%.     

2，6-双（3’-溴甲基-1’-吡唑基）-4-溴吡啶的合成与表征

以2,6-双（3’-甲基-1’-吡唑基）4-氨基吡啶为原料,经重氮化,溴化合成了新型时间分辨荧光免疫分析双功能螯合剂中间体2,6-双（3＇-溴甲基-1’-吡唑基）4-溴吡啶．结构通过IR,MS,^1HNMR和元素分析进行了表征,对合成条件进行了探讨．     

BCL-2选择性抑制剂——ABT-199的合成工艺改进

以3,3-二甲基环己酮(2)为原料,经5步反应制得中间体1-氯-4-［2-(氯甲基)-5,5-二甲基环己基-1-烯］苯（5）;以5-溴-7-氮杂吲哚为原料,经3步反应制得制得5-羟基-1-三异丙基硅基-7-氮杂吲哚（8）; 8与4-［3-氟-4-(甲氧基羰基)苯基］哌嗪-1-甲酸叔丁酯（9）经取代反应制得4-｛3-［(7-氮杂吲哚)氧］-4-(甲氧基羰基)苯基｝哌嗪-1-甲酸叔丁酯（10）;10脱保护后与5进行S_N2取代反应,所得中间体与3-硝基-4-｛［（四氢-2H-吡喃-4-基)甲基］氨基｝苯磺酰胺经缩合反应合成了BCL-2选择性抑制剂ABT-199,总收率28.4%,其结构经¹H NMR和ESI-MS确证。     

泰地唑胺的合成工艺改进

以4-溴-3-氟苯胺为原料,用氯甲酸苄酯保护氨基后,采用一锅两步法制得关键中间体--N-苄氧羰基-3-氟-4-［2-(2-甲基四唑-5-基)吡啶-5-基］苯胺（6）; 6在二异丙基氨基锂作用下与(R)-丁酸缩水甘油酯经环合反应合成了泰地唑胺,总收率53.2%,含量98.5%,其结构经¹H NMR和LC-MS确证。     

新型吡虫啉类化合物的合成

以6-氯-3-氯甲基吡啶为原料,经水解和氧化制得6-氯-3-醛基吡啶(3);3与丙二腈反应制得关键中间体——2-(6-氯-3-亚甲基吡啶)丙二腈(4);4与杂环烯酮缩胺经加成-异构化-环化反应合成了5个新型的吡虫啉类化合物,其结构经1H NMR,13C NMR,IR,HR-EI-MS和MS表征。     

新型苯并咪唑衍生物的合成及其抗凝血活性

以3-［(3-氨基-4-甲基氨基苯甲酰)吡啶-2-基氨基］丙酸乙酯为原料,与4-氰基-3-氟苯取代基乙酸经环化反应制得3-【【2-｛［(4-氰基-3-氟苯取代基）甲基］-1-甲基-1-H-苯并咪唑-5-基｝羰基】吡啶-2-基】氨基丙酸乙酯（3a, 3e）; 3经水解和酰胺化反应制得3-【【【2-｛［(4-氰基-3-氟苯基)取代基］甲基｝-1-甲基-1H-苯并咪唑-5-基】羰基】吡啶-2-基氨基】丙酰取代胺基（6a~6h）;6与乙酰氧肟酸经环合反应合成了8个新型的苯并咪唑衍生物（7a~7h）,其结构经1H NMR和HR-ESI-MS表征。抗凝血活性结果表明： 7a和7c的抗凝血活性最好,其aPTT值分别为(83.1±4.2) s和(80.7±2.9) s,优于阳性对照药达比加群酯(75.3±2.1)s。     

2-氨基-3-氰基-4-芳基-6-二茂铁基吡啶的合成

以乙酰二茂铁、芳香醛、丙二腈为原料, 在乙酸铵存在下以乙醇为溶剂, 采用一锅煮的方法合成了8个2-氨基-3-氰基-4-芳基-6-二茂铁基吡啶化合物, 产率中等. 并通过X射线衍射分析确证产物4e的结构.     

吡啶桥联的聚酰亚胺的合成与性能研究

以3,4-二甲基苯乙酮与3,5-双(三氟甲基)苯甲醛为原料,通过Chichibabin反应制备了吡啶桥联的四甲基化合物,该化合物再经氧化、脱水反应制备了主链含有吡啶环、侧链带有双三氟甲基取代苯侧基的新型含氟芳香族二酐单体,2,6双(3′,4′-二羧基苯基)-4-(3″-,5″-双三氟甲基苯基)吡啶二酐(6FDAPA).FT IR、NMR、质谱以及元素分析等测试结果表明,6FDAPA的结构与预期的相符.利用6FDAPA与另外一种不含氟的二酐单体2,6双(3′,4′二羧基苯基)4苯基吡啶二酐(DAPA)分别与含氟二胺单体,1,4双(2三氟甲基4氨基苯氧基)苯(6FAPB)通过两步热亚胺化法制备了两种聚酰亚胺(PI)薄膜.测试结果表明,6FDAPA6FAPB(PI2)与DAPA6FAPB(PI1)相比具有相近的耐热性能,玻璃化转变温度为280℃,起始热分解温度为580℃、700℃时的重量保持率64.5%.同时PI2具有更为优良的透光性,紫外可见光谱(UV Vis)测试表明,PI2与PI1薄膜在450nm处的透光率分别为85.7%与69.4%.     

Synthesis, and analgesic and antiparkinsonian activities of thiopyrimidine, pyrane, pyrazoline, and thiazolopyrimidine derivatives from 2-chloro-6-ethoxy-4-acetylpyridine

A series of substituted pyridine derivatives were prepared from 2-chloro-6-ethoxy-4-acetylpyridine, which was prepared from the corresponding citrazinic acid as starting material. Reaction of acetylpyridine with thiophene-2-carboxaldehyde afforded the 2-chloro-6-ethoxy-4-β-(2-thienyl)acryloylpyridine, which was reacted with malononitrile in refluxing ethanol in the presence of piperidine as a catalyst to afford the cyanoaminopyrane derivative. Acryloylpyridine was treated with urea or guanidine hydrochloride in refluxing ethanolic potassium hydroxide to give the corresponding pyrimidinone and aminopyrimidine derivatives. The latter was condensed with hydrazine hydrate or phenyl hydrazine to give pyrazoline and N-phenylpyrazoline derivatives. Finally, cycloaddition reaction of acryloylpyridine with thiourea yielded thioxopyrimidine, which was treated with 2-bromopropionic acid, 3-bromopropionic acid, or bromoacetic acid to yield methylthiazolo-, thiazino-, and thiazolopyrimidine derivatives. The arylmethylene derivative was prepared by reacting thiazolopyrimidine with benzaldehyde or by reacting thioxopyrimidine with benzaldehyde and bromoacetic acid in one step. The pharmacological screening showed that many of these compounds have good analgesic and antiparkinsonian activities comparable to Valdecoxib^® and Benzatropine^® as reference drugs.     

Application of novel enantiopure hydroxymethyl-substituted pyridine derivatives in asymmetric catalysis

The synthetic modification of enantiopure hydroxymethyl-substituted pyridine derivatives leading to novel chiral ligands is described. A set of these pyridine derivatives was examined as ligands in asymmetric transformations such as enantioselective alkylations or alkynylations of aldehydes, the asymmetric copper-catalyzed Henry reaction and the asymmetric allylation of benzaldehyde with allyl(trichloro)silane. This first screening revealed that several of the pyridine derivatives prepared are effective ligands affording high yields and good enantioselectivities. The asymmetric alkylation of aldehydes with diethylzinc provided yields of up to 93% with an enantiomeric excess of up to 88%. The asymmetric Henry reaction was also efficiently catalyzed by one of the prepared ligands affording (S)-2-nitro-1-phenylethanol in 68% yield and with 70% ee.     

1-Ethyl-1,4-dihydro-4-oxo-7-(pyridinyl)-3-quinolinecarboxylic acids. I. Synthesis of 3- and 4-(3-aminophenyl)pyridine intermediates

A series of substituted 3- and 4-(3-aminophenyl)pyridines has been prepared as intermediates for the synthesis of some 1-alkyl-1,4-dihydro-4-oxo-7-pyridinyl-3-quinolinecarboxylic acids. The Hantzsch, Hauser and other pyridine syntheses were used. 4-(3-Aminophenyl)pyridine was prepared via 3-(4-pyridinyl)-2-cyclohexen-1-one using the Semmler-Wolff reaction.     

β-CD与间羧基苯磺酰氯及Fe^3^+构筑氧化还原酶

用β-CD与间羧基苯磺酰氯及三氯化铁反应, 制得了双(6-氧-间羧基苯磺酰基)-β-CD.Fe^3^+配合物, 以此配合物作催化剂, 将苯甲醇高速率氧化成苯甲醛和苯甲酸, 其反应速率是三氯化铁的1.4×10^4倍。     

Convenient synthesis and anticancer evaluation of novel pyrazolyl-thiophene,thieno[3,2-b]pyridine,pyrazolo[3,4-d]thieno[3,2-b]pyridine and pyrano[2,3-d]thieno[3,2-b]pyridine derivatives

The newly synthesized 3-(3-amino-5-(phenylamino)-4-(phenylcarbamoyl)thiophen-2-yl)-3-oxopropanoate was utilized as a precursor for the synthesis of pyrazolyl-thiophene derivative, which undergoes cyclization upon treatment with benzaldehyde derivatives to provide pyrazolo[3,4-d]thieno[3,2-b]pyridines. Basic treatment of pyrazolyl-thiophene derivative with phenyl isothiocyanate followed by subsequent addition of chloroacetone and/or ethyl bromoacetate yielded the thiazolylidene-pyrazolyl thiophenes. In addition, the building block 3-(3-amino-5-(phenylamino)-4-(phenylcarbamoyl)thiophen-2-yl)-3-oxopropanoate was converted into the corresponding thieno[3,2-b]pyridine compounds through its reactions with (DMF-DMA) and/or heating in sodium ethoxide. Moreover, the reaction of 7-hydroxy-5-oxo-N-phenyl-2-(phenylamino)-4,5-dihydrothieno[3,2-b]pyridine-3-carboxamide with 2-arylidenemalononitrile produced the new annulated pyrano[2,3-d]thieno[3,2-b]pyridines. The prepared thiophene-based compounds were evaluated against HepG2, PC3, and MCF-7 cancer cells, and normal fibroblast cell (WI38). The pyrazolo[3,4-d]thieno[3,2-b]pyridine and pyrano[2,3-d]thieno[3,2-b]pyridine compounds substituted with chlorophenyl group presented promising cytotoxic activities against HepG2 cancer cell line without any human toxicity. Docking study for the synthesized thiophene compounds delivered valuable insights about the binding interactions with the crystal structure of NS5B enzyme with PDB ID (4TLR).     

Biocatalytic preparation of optically active 4-(N,N-dimethylamino)pyridines for application in chemical asymmetric catalysis

4-Chloro-2-(1-hydroxybenzyl)pyridine and 4-chloro-2-(1-hydroxyalkyl)pyridines were obtained with moderate to excellent enantiomeric excesses and high isolated yields by bioreduction with Baker’s yeast of the corresponding ketones. The resulting optically active alcohols were transformed into adequate DMAP derivatives, which have been applied in asymmetric catalytic processes as nucleophilic catalysts in the stereoselective chemical alkoxycarbonylation of 1-phenylethanol or as chiral ligands in the enantioselective addition of diethylzinc to benzaldehyde.     

Unexpected intermediate 1-phenyl-2-(4-pyridyl)ethanol isolated from benz-aldehyde and 4-picoline condensation reaction

The unexpected intermediate 1-phenyl-2-(4-pyridyl)ethanol or 4-[2-(1-hydroxy-1-phenyl)ethyl]pyridine was isolated from the condensation reaction of 4-methylpyridine with benzaldehyde to form the model compound 4-styrylpyridine in the absence of a condensing agent. Spectroscopic data (NMR, IR and UV-VIS) gave evidence that the isolated compound is actually the alcohol just before the dehydration which yields the double bond of the 4-styrylpyridine and the structure was confirmed by single-crystal x-ray analysis. The isolation method from the reaction mixture was difficult at first, but now a 10% yield has been obtained, not only in powder form but as crystals good enough for R-X structural analysis.     

HETEROAROMATIC POLYMERS — HIGH TEMPERATURE POLYPYRROLONES DERIVED FROM 2,6-BIS(3'',4''-DIAMINOPHENYL)-4-BIPHENYLPYRIDINE AND VARIOUS AROMATIC DIANHYDRIDES

A new type of aromatic tetraarnine containing biphenyl moiety in the side chain was synthesized via a modified Chichibabin＇s reaction. 3-Nitro-4-acetamidoacetophenone was reacted with 4-phenyl benzaldehyde in the presence of ammonium acetate to obtain 2,6-bis（3＇,4＇-diaminophenyl）-4-biphenyl pyridine （DPPA）. A series of polypyrrolones （PPys） were prepared using tetraamine and various aromatic dianhydrides via a two-step cyclization procedure. All the PPys show excellent high temperature stabilities with the initial decomposition temperatures of 530-549℃ and residual weight ratio of 49%-80% at 750℃ in nitrogen. The polymers exhibit no apparent glass transition temperatures （Tgs） except PPy-1 （Tg= 327℃）, which is derived from tetraamine DPPA and 2,2-bis[4-（3＇,4＇-dicarboxyphenoxy）-phenyl]propane dianhydride （BPADA）. In addition, the polymers have acceptable mechanical properties with the tensile strength of 65-94 MPa. The PPy films show excellent hydrolysis-resistance in alkaline aqueous medium and could maintain most of the properties even after boiling in 10% aqueous sodium hydroxide solution for a week.